Compare SSRM & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSRM | SHC |
|---|---|---|
| Founded | 1946 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.2B |
| IPO Year | 1997 | 2020 |
| Metric | SSRM | SHC |
|---|---|---|
| Price | $27.07 | $16.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $40.25 | $21.44 |
| AVG Volume (30 Days) | 2.3M | ★ 2.5M |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | ★ 0.21% | N/A |
| EPS Growth | ★ 243.41 | 68.75 |
| EPS | 0.34 | ★ 0.48 |
| Revenue | ★ $1,629,637,000.00 | $1,163,617,000.00 |
| Revenue This Year | $29.97 | $6.90 |
| Revenue Next Year | $8.41 | $5.48 |
| P/E Ratio | $82.29 | ★ $34.45 |
| Revenue Growth | ★ 63.68 | 5.74 |
| 52 Week Low | $19.69 | $13.09 |
| 52 Week High | $39.44 | $19.85 |
| Indicator | SSRM | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 38.92 | 37.62 |
| Support Level | $24.85 | $14.93 |
| Resistance Level | $28.74 | $16.41 |
| Average True Range (ATR) | 1.26 | 0.61 |
| MACD | 0.15 | -0.12 |
| Stochastic Oscillator | 36.28 | 21.42 |
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.